Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print April 17, 2007
DOI: 10.2337/db06-1065

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1065v1
56/7/1856    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lessard, S. J.
Right arrow Articles by Hawley, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lessard, S. J.
Right arrow Articles by Hawley, J. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Tissue-specific effects of Rosiglitazone and Exercise in the treatment of lipid-induced insulin resistance.

Sarah J. Lessard1, Donato A. Rivas1,,2, Zhi-Ping Chen4, Arend Bonen3, Mark A. Febbraio1,,6, Donald W. Reeder2, Bruce E. Kemp4,,5, Ben B. Yaspelkis, III2, and John A. Hawley1

1School of Medical Sciences, RMIT University,Australia
2Dept. of Kinesiology, California State University, Northridge, USA
3Dept. of Human Health and Nutritional Sciences, University of Guelph, Canada
4St. Vincent's Institute, University of Melbourne, Australia
5CSIRO Molecular & Health Technologies, Parkville, Australia
6Baker Heart Research Institute, Prahran, Australia

Correspondence: john.hawley{at}rmit.edu.au

OBJECTIVE:Both pharmacological intervention (i.e. thiazolidinediones [TZD]), and lifestyle modification (i.e. exercise training) are clinically effective treatments for improving whole-body insulin sensitivity. However, the mechanism(s) by which these therapies reverse lipid-induced insulin resistance in skeletal muscle is unclear.

RESEARCH DESIGN AND METHODS:We determined the effects of 4 wk Rosiglitazone (RSG) treatment and exercise training (EX), as well as their combined actions (EX RSG) on lipid and glucose metabolism in high-fat fed rats.

RESULTS:High-fat feeding (HF) resulted in decreased muscle insulin sensitivity, which was associated with increased rates of palmitate uptake and the accumulation of the fatty acid metabolites ceramide and diacylglycerol. Impairments in lipid metabolism were accompanied by defects in the Akt/AS160 signalling pathway. EX, but not RSG treatment reversed these impairments resulting in improved insulin-stimulated glucose transport and increased rates of fatty acid oxidation in skeletal muscle. The improvements to glucose and lipid metabolism observed with EX were associated with increased AMPK{alpha}1 activity, increased expression of Akt1, PGC-1 and GLUT4 and a decrease in AS160 expression. In contrast, RSG treatment exacerbated lipid accumulation and decreased insulin-stimulated glucose transport in skeletal muscle. However, RSG, but not EX, increased adipose tissue GLUT4 and ACC expression. Both EX and RSG decreased liver triacylglycerol content.

CONCLUSION:Although both interventions can improve whole-body insulin sensitivity, our results show they produce divergent effects on protein expression and triglyceride storage in different tissues. Accordingly, exercise training and Rosiglitazone may act as complementary therapies for the treatment of insulin resistance.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
P. Dallaire, K. Bellmann, M. Laplante, S. Gelinas, C. Centeno-Baez, P. Penfornis, M.-L. Peyot, M. G. Latour, J. Lamontagne, M. E. Trujillo, et al.
Obese Mice Lacking Inducible Nitric Oxide Synthase Are Sensitized to the Metabolic Actions of Peroxisome Proliferator-Activated Receptor-{gamma} Agonism
Diabetes, August 1, 2008; 57(8): 1999 - 2011.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. B. Yaspelkis III, S. J. Lessard, D. W. Reeder, J. J. Limon, M. Saito, D. A. Rivas, I. Kvasha, and J. A. Hawley
Exercise reverses high-fat diet-induced impairments on compartmentalization and activation of components of the insulin-signaling cascade in skeletal muscle
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E941 - E949.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.